The US Food and Drug Administration (FDA) has granted accelerated approval to pembrolizumab (brand name Keytruda) for patients with classical Hodgkin lymphoma (cHL).
Source: RX Wiki
Please click on image for full article!
Source: RX Wiki
Please click on image for full article!